Through its research partner at the University of Queensland in Australia, PreveCeutical Medical (PRVCF, PREV) has continued moving forward with a wide-ranging drug research platform. The arrangement gives the Company exclusive license of resulting technologies and provides for royalties to UniQuest from future revenue streams when the therapeutic candidates reach commercial stage. Recent advances demonstrate […]
Category: PRVCF
Updated Coverage – PreveCeutical Medical (PRVCF, PREV)
It takes tenacity to push a biotechnology agenda forward. Costly, time consuming and inherently complex, research and development projects are fraught with uncertainty. The second quarter financial report of Pharmaceutical Medical makes clear the Company is moving forward despite limited capital and a daunting work load shared by a small team. The Company has partnered […]
Updated Coverage – PreveCeutical Medical (PRVCF, PREV)
Coverage of PreveCeutical Medical (PRVCF, PREV) has been updated with a discussion of recent accomplishments. PreveCeutical is an early stage life sciences company with a focus on compounds using natural substances for health and wellness products. The Company has licensed a clutch of natural health products for sleep, pain and anxiety treatment, including a commercially-proven […]
Updated Coverage – PreveCeutical Medical (PRVCF, PREV)
PreveCeutical Medical (PRVCF, PREV) is an early stage life sciences company with a focus on curative and therapeutic compounds based on natural substances. Recent announcements point to value creation by PreveCeutical in recent months. The research and development team has made significant progress with several projects. The updates appear to confirm the Company has been […]
Updated Coverage – PreveCeutical Medical, Inc. (PRVCF, PREV)
Early stage biotechnology company PreveCeutical Medical (PRVCF: OTC, PREV: CN) has made considerable progress with an ambitious research pipeline focused on preventative and curative medicines. The Company has claimed several achievements in recent months, moving projects “closer to goal.’ We have had high hopes for the Company in 2018, and so far we have not […]